Deficiency of Interleukin‐1 Receptor Antagonist Responsive to Anakinra

Charlotte Schnellbacher, Giovanna Ciocca, Roxanna Menendez, Ivona Aksentijevich, Raphaela Goldbach‐Mansky, Ana M. Duarte, Rafael Rivas‐Chacon

Pediatric Dermatology · 2012 · 78 citations · 4 references

Concepts

Abstract

We describe a 3-month-old infant who presented to our institution with interleukin (IL)-1 receptor antagonist deficiency (DIRA), which consists of neutrophilic pustular dermatosis, periostitis, aseptic multifocal osteomyelitis, and persistently high acute-phase reactants. Skin findings promptly improved upon initiation of treatment with anakinra (recombinant human IL-1 receptor antagonist), and the bony lesions and systemic inflammation resolved with continued therapy.

References

4